Zacks Investment Ideas feature highlights: UnitedHealth Group

For Immediate ReleaseChicago, IL – May 20, 2025– Today, Zacks Investment Ideas feature highlights UnitedHealth Group UNH.Follow UNH Insiders as They Buy $30 Million in Stock?What Does UNH Do?Zacks Rank #5 (Strong Sell) stock UnitedHealth Group is the largest health insurance company in the United States. UNH, which generated ~$400 billion in revenue last year, provides a variety of health care products and services, including health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. Meanwhile, the company boasts the largest and most diverse membership base within the managed-care organization market, giving it significant competitive advantages. Through several strategic acquisitions, UNH has transformed from a pure health insurer to a comprehensive healthcare provider.UNH Faces Several HeadwindsUntil recently, UNH stock was a model of resilience. Over the past year, however, UNH has had to weather a monumental storm of headwinds including a spike in medical costs and expenses, a cyber-attack, and the murder of UNH health insurance unit CEO Brian Thompson (and some of the backlash that came with it).Despite the barrage of negative news headlines, UNH shares traded just shy of all-time highs as early as last month. However, UNH shares have been destroyed since then, plunging more than 50% in a month and marking the healthcare juggernaut's worst drawdown since the Great Financial Crisis of 2008.Why Are UNH Shares Falling?While the price action was firm until recently, investor confidence was rattled and shares unraveled rapidly after the unexpected departure of CEO Andrew Witty, a Medicare investigation into UNH, and suspended earnings guidance.Should You Buy UNH Stock?   With negative news reaching a fever pitch, shares plunging, and investor fear rising, is now the time to buy shares of UNH?Insiders Buy More than $30 Million of UNHHeavy insider buying in a short period is one of the best "tells" savvy investors can observe for a prospective stock. Last week, UNH insiders put their money where their mouth is and bought a sizable amount of stock.The latest insider trading disclosure shows that returning CEO Stephen Hemsley, who had a previous and successful stint as UNH CEO from 2006 to 2017, bought $25 million worth of shares on Friday, May 16th. Meanwhile, UNH President and CEO John F Rex accumulated nearly $5 million worth of UNH while three directors also looked to take advantage of lower stock prices. Such concentrated insider buying leads me to believe that insiders are confident that the company's issues will be resolved – and possibly soon.Investors are Bearish on UNH Stock"Google Trends" analyzes the popularity of search queries on the internet. The term "Short UNH" has spiked to its highest levels in history. Previous spikes have marked significant intermediate bottoms in the stock.UNH Technicals Show Bottoming ActionThe UNH daily chart illustrates significant signs of downside exhaustion, including a hammer reversal candle, extreme volume (the highest since the Great Financial Crisis), and a near-maximum oversold reading.Bottom LineThough UnitedHealth Group faces a barrage of negative news, recent heavy insider buying and technical indicators suggest peak pessimism and a potential bottom in the stock.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.comhttps://www.zacks.comPast performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report UnitedHealth Group Incorporated (UNH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks